Elizabeth Phillips

InstitutionMurdoch University
AddressNashville
Tennessee
United States
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 17 Covid-19 publications, with a maximum of 3 publications in April 2021 and June 2021
    All Publications
    Bar chart showing 175 publications over 20 distinct years, with a maximum of 25 publications in 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Krantz MS, Kwah JH, Stone CA, Phillips EJ, Ortega G, Banerji A, Blumenthal KG. Safety Evaluation of the Second Dose of Messenger RNA COVID-19 Vaccines in Patients With Immediate Reactions to the First Dose. JAMA Intern Med. 2021 11 01; 181(11):1530-1533. PMID: 34309623.
      Citations: 10     Fields:    Translation:Humans
    2. Bejan CA, Cahill KN, Staso PJ, Choi L, Peterson JF, Phillips EJ. DrugWAS: Drug-wide Association Studies for COVID-19 Drug Repurposing. Clin Pharmacol Ther. 2021 12; 110(6):1537-1546. PMID: 34314511.
      Citations:    Fields:    Translation:Humans
    3. Phillips EJ. Allergic Reactions After COVID-19 Vaccination-Putting Risk Into Perspective. JAMA Netw Open. 2021 08 02; 4(8):e2122326. PMID: 34463751.
      Citations:    Fields:    Translation:HumansPHPublic Health
    4. Krantz MS, Stone CA, Rolando LA, Nobis AE, Koo G, Corey KB, Bluestein SB, Staso PJ, Campbell EM, Phillips EJ. An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history. J Allergy Clin Immunol Pract. 2021 10; 9(10):3807-3810. PMID: 34293499.
      Citations: 1     Fields:    Translation:Humans
    5. Krantz MS, Bruusgaard-Mouritsen MA, Koo G, Phillips EJ, Stone CA, Garvey LH. Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose! Allergy. 2021 09; 76(9):2916-2920. PMID: 34028041.
      Citations: 6     Fields:    Translation:Humans
    6. Shaker MS, Phillips E, Blumenthal KG, Abrams EM, Banerji A, Oppenheimer J, Vander Leek TK, Mack DP, Wickner PG, Singer AG, Khan DA, Greenhawt M. Reply to "How important is the second dose of the COVID-19 mRNA vaccine?" J Allergy Clin Immunol Pract. 2021 06; 9(6):2537-2539. PMID: 34112481.
      Citations:    Fields:    Translation:Humans
    7. Krantz MS, Liu Y, Phillips EJ, Stone CA. COVID-19 vaccine anaphylaxis: PEG or not? Allergy. 2021 06; 76(6):1934-1937. PMID: 34128562.
      Citations: 3     Fields:    Translation:Humans
    8. Shaker M, Phillips E, Blumenthal KG, Abrams EM, Banerji A, Oppenheimer J, Vander Leek TK, Mack DP, Wickner PG, Singer AG, Khan DA, Greenhawt M. The Importance of a Timely Second Dose of the 2021 COVID-19 mRNA Vaccine Depends on the Protection Afforded by a First Dose and Subsequent Risk of Anaphylaxis. J Allergy Clin Immunol Pract. 2021 07; 9(7):2556-2561. PMID: 33892171.
      Citations: 1     Fields:    Translation:HumansPHPublic Health
    9. Banerji A, Wolfson AR, Wickner PG, Cogan AS, McMahon AE, Saff R, Robinson LB, Phillips E, Blumenthal KG. COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach. J Allergy Clin Immunol Pract. 2021 06; 9(6):2135-2138. PMID: 33866033.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    10. Banerji A, Phillips E, Saff R, Wickner PG, Robinson LB, Wolfson AR, Williams P, Khan DA, Blumenthal KG. Reply to "PEG skin testing for COVID-19 allergy". J Allergy Clin Immunol Pract. 2021 04; 9(4):1765-1766. PMID: 33838846.
      Citations:    Fields:    Translation:Humans
    11. Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. Reply. N Engl J Med. 2021 03 11; 384(10):e37. PMID: 33567190.
      Citations: 5     Fields:    Translation:Humans
    12. Tarke A, Sidney J, Kidd CK, Dan JM, Ramirez SI, Yu ED, Mateus J, da Silva Antunes R, Moore E, Rubiro P, Methot N, Phillips E, Mallal S, Frazier A, Rawlings SA, Greenbaum JA, Peters B, Smith DM, Crotty S, Weiskopf D, Grifoni A, Sette A. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep Med. 2021 02 16; 2(2):100204. PMID: 33521695.
      Citations: 75     
    13. Banerji A, Wickner PG, Saff R, Stone CA, Robinson LB, Long AA, Wolfson AR, Williams P, Khan DA, Phillips E, Blumenthal KG. mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach. J Allergy Clin Immunol Pract. 2021 04; 9(4):1423-1437. PMID: 33388478.
      Citations: 86     Fields:    Translation:Humans
    14. Castells MC, Phillips EJ. Maintaining Safety with SARS-CoV-2 Vaccines. N Engl J Med. 2021 02 18; 384(7):643-649. PMID: 33378605.
      Citations: 87     Fields:    Translation:Humans
    15. Camilleri M, Sive J, Wilson W, Pang G, Jenner R, Phillips E, Popat R, Ramasamy K, Bygrave C, Dadaga T, Streetly M, Cavenagh J, Chapman M, Barrington S, Pike L, Owen R, Clifton-Hadley L, Yong K. COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial. Br J Haematol. 2021 01; 192(1):e14-e16. PMID: 33222153.
      Citations: 3     Fields:    Translation:HumansCTClinical Trials
    16. Copaescu A, Smibert O, Gibson A, Phillips EJ, Trubiano JA. The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J Allergy Clin Immunol. 2020 09; 146(3):518-534.e1. PMID: 32896310.
      Citations: 34     Fields:    Translation:HumansCellsPHPublic Health
    17. Mateus J, Grifoni A, Tarke A, Sidney J, Ramirez SI, Dan JM, Burger ZC, Rawlings SA, Smith DM, Phillips E, Mallal S, Lammers M, Rubiro P, Quiambao L, Sutherland A, Yu ED, da Silva Antunes R, Greenbaum J, Frazier A, Markmann AJ, Premkumar L, de Silva A, Peters B, Crotty S, Sette A, Weiskopf D. Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. Science. 2020 10 02; 370(6512):89-94. PMID: 32753554.
      Citations: 309     Fields:    Translation:HumansCellsPHPublic Health
    Phillips's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (300)
    Explore
    _
    Co-Authors (106)
    Explore
    _
    Similar People (60)
    Explore
    _